ESR1 and breast cancer: Increased endothelial cell activation in triple-negative MDA-MB-231 and estrogen receptor-positive MCF-7 breast cancer cells appears to result in elevated VWF release, which was attributed to the excessive secretion of VEGF-A by the cell lines studied.